Moderna | MRNA - PE Price to Earnings


Moderna reported 27.22 in PE Price to Earnings for its fiscal quarter ending in June of 2023.





Pe Change Date
Acadia Pharmaceuticals 10.08 1.53 Mar/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
Amgen 19.84 5.47 Mar/2026
Biogen 13.7 0.32 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Celltrion 67.83 17.74 Dec/2025
Cspc Pharmaceutical 24.4 1.13 Dec/2025
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 59.75 6.76 Mar/2026
Esperion Therapeutics 129.79 129 Dec/2024
Gilead Sciences 17.7 2.07 Mar/2026
GlaxoSmithKline 14.87 3.72 Mar/2026
Incyte 15.35 0.51 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Organigram Holdings 235 224.49 Sep/2025
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 19.13 1.72 Mar/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Qiagen NV 20.54 0.1 Dec/2025
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Sarepta Therapeutics 27.27 0 Dec/2025
Sartorius 43.44 84.64 Mar/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tilray 11.56 80.19 Sep/2025
United Therapeutics 20.42 3.1 Mar/2026
Vertex Pharmaceuticals 25.82 0.33 Mar/2026
Zealand Pharma A/S 5.13 0.16 Dec/2025
Zz Pientze Pharmaceu 47.68 1.35 Mar/2026